IPO Trending
GLANDSME / NSE, BSEListed

Gland Pharma Limited

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

₹1,490 - ₹1,500Open
Listed Price1710.00
Listing Gain+14.00%
TimelineBookbuilding IPO
Open09 Nov 2020
Close11 Nov 2020
Allotment18 Nov 2020
Listing20 Nov 2020

Quota Reservation Portions

QIBPortion: 2,15,98,483 shares
50%
HNIPortion: 64,79,546 shares
15%
RetailPortion: 1,51,18,939 shares
34%

Minimum Application Bracket Matrix

Retail1 lots / 10 shares
₹15,000
sHNI14 lots / 140 shares
₹2,10,000
bHNI67 lots / 670 shares
₹10,05,000

About the Company

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

Company Promoters

Fosun Pharma Industrial Pte. LtdShanghai Fosun Pharmaceutical (Group) Co. Ltd